Abstracts

IMPACT OF INTEGRASE INHIBITORS ON CARDIOVASCULAR EVENTS IN PERSONS STARTING ART

Background: Integrase strand transfer inhibitors (INSTI) have become essential components of antiretroviral therapy (ART). A recent study suggests that INSTI-based ART may lead to an increased risk for cardiovascular (CVD) events in the first two years compared to other ART combinations. However, analyzing treatment-naïve and treatment-experienced individuals together may have introduced bias. We estimated the…

MICROBIOTA-DERIVED METABOLITES ARE POWERFUL BIOMARKERS FOR ANAL CANCER PREVENTION

Background: The risk of anal cancer is markedly increased in PWH, especially in MSM, who exhibit specific microbiota signatures, possibly contributing to the greater HPV persistence and oncogenic potential. The low specificity of the current screening strategy for detecting high-grade squamous intraepithelial lesions (HSIL) hinders anal cancer prevention. We investigated in anal cytology samples microbiota…

PHYLODYNAMICS OF HIV-1 VARIANT ACROSS POLAND AND UKRAINE

Background: In the countries of Eastern Europe (Russia, Belarus, Ukraine), where the HIV-1 epidemics are expanding, the A6 variant remains predominant. After the initiation of the war in Ukraine, Poland has become the principal refuge for Ukrainian citizens; however, migration from this country has been common over the last decade. Evolutionary analyses of viral sequences…

A LOSS OF ERα ATTENUATES DTG-MEDIATED DISRUPTION OF THERMOGENESIS IN BROWN ADIPOCYTES

Background: Antiretroviral therapy (ART) containing integrase strand transfer inhibitors (INSTI) has been associated with weight gain in both ART-initiation and switch studies, especially in women, but the underlying mechanisms of sex-difference are unclear. Estrogen is recognized as a master regulator of the energy homeostasis and is a major determinant of sex differences in the control…

HIV-RELATED KAPOSI SARCOMA IN EAST AFRICA: CONTEMPORARY UPDATE ON STAGE AND SURVIVAL

Background: Stage at time of diagnosis and survival after diagnosis are critical parameters regarding the control of any cancer in any geographical setting. Unlike in resource-rich settings where publicly funded cancer surveillance routinely monitors these parameters, these data are non-existent through routine means in resource-limited areas. This is particularly relevant for Kaposi sarcoma (KS) in…

SINGLE-CELL EPIGENETIC, TRANSCRIPTIONAL, AND PROTEIN STATES OF HIV RESERVOIR

Background: The cellular program dictating productive HIV-1 infection versus latency remains unknown. Understanding the epigenetic regulators and transcriptional program of HIV-infected cells with undetectable HIV expression (HIV DNA+ RNA–) and active HIV expression (HIV RNA+) informs HIV eradication strategies. Methods: We performed DOGMA-seq and TREK-seq to simultaneously capture 171 surface proteins, cellular transcriptome (RNA-seq), transcription…

EFFECTS OF EPLERENONE ON MYOCARDIAL PERFUSION AND FUNCTION: THE MIRACLE HIV STUDY

Background: Subclinical cardiovascular disease (CVD) remains increased among persons with HIV(PWH). We have shown unique renin-angiotensin-aldosterone system (RAAS) physiology among PWH such that increased RAAS activation is associated with non-traditional CVD risk factors, including visceral adiposity, insulin resistance, inflammation, and altered natriuretic peptides. We sought to understand how RAAS blockade may improve CVD in HIV.…

WEIGHT AND METABOLIC CHANGES WITH CABOTEGRAVIR+RILPIVIRINE LONG-ACTING OR BICTEGRAVIR

Background: Integrase strand transfer inhibitors (INSTIs) and tenofovir alafenamide–based regimens are potentially associated with weight gain and metabolic perturbations in people living with HIV (PLWH). Cabotegravir (CAB), an INSTI, plus rilpivirine (RPV), a non-nucleoside reverse transcriptase inhibitor, administered monthly or every 2 months (Q2M) is the first complete long-acting (LA) regimen recommended by treatment guidelines…